Sutro Biopharma Inc.

NASDAQ: STRO · Real-Time Price · USD
0.90
0.12 (15.37%)
At close: Aug 15, 2025, 12:53 PM
15.37%
Bid 0.66
Market Cap 75.87M
Revenue (ttm) 66.43M
Net Income (ttm) -245.22M
EPS (ttm) -2.51
PE Ratio (ttm) -0.36
Forward PE -0.79
Analyst Hold
Ask 1.02
Volume 876,660
Avg. Volume (20D) 809,283
Open 0.79
Previous Close 0.78
Day's Range 0.78 - 0.96
52-Week Range 0.52 - 5.17
Beta 1.67

About STRO

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol STRO
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for STRO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Sutro Biopharma has released their quartely earnings on Aug 7, 2025:
  • Revenue of $63.74M exceeds estimates by $48.71M, with 147.98% YoY growth.
  • EPS of -0.14 exceeds estimates by 0.33, with 76.27% YoY growth.
  • Next Earnings Release

    Sutro Biopharma Inc. is scheduled to release its earnings on Nov 12, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 months ago
    +10.2%
    MicroSutro Biopharma shares are trading higher aft... Unlock content with Pro Subscription
    5 months ago
    -35.19%
    Sutro Biopharma shares are trading lower after B of A Securities downgraded the stock from Buy to Underperform and cut its price target from $11 to $1.